Actinogen Medical Ltd. (ATGGF)
0.06
0.00 (0.00%)
USD |
OTCM |
Oct 07, 16:00
Actinogen Medical Max Drawdown (5Y) : 99.20% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.20% |
| August 31, 2026 | 99.20% |
| July 31, 2026 | 99.20% |
| June 30, 2026 | 99.20% |
| May 31, 2026 | 99.20% |
| April 30, 2026 | 99.20% |
| March 31, 2026 | 90.00% |
| February 28, 2026 | 90.00% |
| January 31, 2026 | 90.00% |
| December 31, 2025 | 90.00% |
| November 30, 2025 | 90.00% |
| October 31, 2025 | 90.00% |
| September 30, 2025 | 90.00% |
| August 31, 2025 | 90.00% |
| July 31, 2025 | 90.00% |
| June 30, 2025 | 90.00% |
| May 31, 2025 | 90.00% |
| April 30, 2025 | 87.51% |
| March 31, 2025 | 87.51% |
| February 28, 2025 | 87.51% |
| January 31, 2025 | 87.51% |
| December 31, 2024 | 87.51% |
| November 30, 2024 | 87.51% |
| October 31, 2024 | 87.51% |
| September 30, 2024 | 87.51% |
| Date | Value |
|---|---|
| August 31, 2024 | 87.51% |
| July 31, 2024 | 87.51% |
| June 30, 2024 | 87.51% |
| May 31, 2024 | 87.51% |
| April 30, 2024 | 87.51% |
| March 31, 2024 | 87.51% |
| February 29, 2024 | 87.51% |
| January 31, 2024 | 87.51% |
| December 31, 2023 | 87.51% |
| November 30, 2023 | 87.51% |
| October 31, 2023 | 87.51% |
| September 30, 2023 | 87.51% |
| August 31, 2023 | 87.51% |
| July 31, 2023 | 87.00% |
| June 30, 2023 | 87.00% |
| May 31, 2023 | 87.00% |
| April 30, 2023 | 87.00% |
| March 31, 2023 | 87.00% |
| February 28, 2023 | 87.00% |
| January 31, 2023 | 85.71% |
| December 31, 2022 | 85.71% |
| November 30, 2022 | 85.71% |
| October 31, 2022 | 85.71% |
| September 30, 2022 | 85.71% |
| August 31, 2022 | 85.71% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Immutep Ltd. | 95.17% |
| CSL Ltd. | 69.95% |
| Ceryvyn Therapeutics Ltd. | 99.95% |
| Propanc Biopharma, Inc. | 100.0% |
| Mesoblast Ltd. | 95.66% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -13.97 |
| Beta (5Y) | 3.076 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 17.37K% |
| Historical Sharpe Ratio (5Y) | 0.001 |
| Historical Sortino (5Y) | 0.2399 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 60.00% |